Bailey Megan D. 4

What Happened

• Megan D. Bailey, EVP and President, Central Labs & International at Labcorp Holdings Inc. (LH), received equity awards on Feb 10, 2026 consisting of 3,300 employee stock options and 1,100 Restricted Stock Units (RSUs). The Form 4 reports these as derivative acquisitions at $0.00 (award/grant), not open-market purchases or sales.

Key Details

• Transaction date: Feb 10, 2026; Form 4 filed Feb 12, 2026 (timely).
• Awards: 3,300 employee stock options (footnote F1) and 1,100 RSUs (footnotes F3, F5).
• Reported price/value: $0.00 for both lines (typical for awarded grants on Form 4).
• Vesting: Options vest in three equal annual installments beginning on the grant date (Feb 10, 2026) (F2). The RSUs vest in three equal annual installments beginning Feb 10, 2027 (F4).
• Shares owned after transaction: The filing does not disclose total common shares held after grant; it does report an aggregate 1,100 RSUs held by the reporting person (F5).
• Transaction code: "A" = award/grant. No immediate sales or cashless exercises reported.

Context

• Employee stock options give the holder the right to buy company shares in the future (subject to vesting and exercise price); RSUs represent a contingent right to receive shares when vested. These grants are a routine form of executive compensation/retention and do not, by themselves, indicate an immediate buy or sell of market stock.